Pages that link to "Q68164270"
Jump to navigation
Jump to search
The following pages link to Antiproteinuric effect of captopril in primary glomerular disease (Q68164270):
Displaying 12 items.
- Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome (Q33562989) (← links)
- Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease (Q35181081) (← links)
- Angiotensin converting enzyme (ACE) inhibitors and renal function. A review of the current status (Q37421062) (← links)
- Angiotensin-converting enzyme inhibitors in chronic renal failure (Q37925770) (← links)
- Urologic management of congenital nephrotic syndrome of the finnish type (Q41724726) (← links)
- Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome (Q44470928) (← links)
- Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. (Q54348402) (← links)
- Long-Term Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Patients With Nephrotic Proteinuria (Q61456193) (← links)
- Angiotensin II receptor regulation in anti-glomerular basement membrane nephritis (Q68591106) (← links)
- Renal effects of angiotensin converting enzyme inhibitors: nondiabetic chronic renal disease (Q68674595) (← links)
- Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin (Q72393821) (← links)
- Management of hyperlipidemia in children with refractory nephrotic syndrome: the effect of statin therapy (Q73138522) (← links)